Toxicity and survival outcomes of autologous stem cell transplant in multiple myeloma patients with renal insufficiency: an institutional comparison between two eras

MLA

Li, Amanda Yan, et al. “Toxicity and Survival Outcomes of Autologous Stem Cell Transplant in Multiple Myeloma Patients with Renal Insufficiency: An Institutional Comparison between Two Eras.” Bone Marrow Transplantation, vol. 55, no. 3, Mar. 2020, pp. 578–85. EBSCOhost, https://doi.org/10.1038/s41409-019-0697-8.

APA

Li, A. Y., Atenafu, E. G., Bernard, R. S., Masih-Khan, E., Reece, D., Franke, N., Tiedemann, R., Prica, A., Trudel, S., Kukreti, V., & Chen, C. I. (2020). Toxicity and survival outcomes of autologous stem cell transplant in multiple myeloma patients with renal insufficiency: an institutional comparison between two eras. Bone Marrow Transplantation, 55(3), 578–585. https://doi.org/10.1038/s41409-019-0697-8

Chicago

Li, Amanda Yan, Eshetu G. Atenafu, Rosanne St. Bernard, Esther Masih-Khan, Donna Reece, Norman Franke, Rodger Tiedemann, et al. 2020. “Toxicity and Survival Outcomes of Autologous Stem Cell Transplant in Multiple Myeloma Patients with Renal Insufficiency: An Institutional Comparison between Two Eras.” Bone Marrow Transplantation 55 (3): 578–85. doi:10.1038/s41409-019-0697-8.